Guidant: Warranty Credits Withheld From Federal Buyers

Guidant, a Boston Scientific subsidiary, agreed to pay $9.25 million in the Guidant warranty credits settlement to resolve allegations that it withheld replacement benefits and inflated device costs to federal health care programs. The government said the company promoted generous credits to help sell pacemakers and defibrillators, then knowingly failed to grant them when covered devices needed replacement. The sales promise and the replacement invoice allegedly told different stories.

The Justice Department announced the civil settlement on September 26, 2011. A whistleblower brought the qui tam case under the False Claims Act.

The Warranty Helped Sell the Device

Guidant allegedly used its replacement-credit program to persuade physicians to choose its products over competing devices. The government’s account describes a sales pitch built around longevity and reliability, reinforced by the credits available if a device needed replacement while under warranty.

That pitch crossed a familiar divide in the implant business. A physician may make or strongly influence the choice of device, while the hospital handles purchasing and receives the manufacturer’s bill. The person hearing the assurance about replacement costs may be different from the person processing the replacement invoice.

The government alleged that Guidant knew it had failed to grant appropriate credits in a large number of cases where products failed under warranty. The covered allegations concerned pacemakers and defibrillators that had been explanted, or removed from patients, while covered by a warranty or another credit program.

How the Overcharge Reached Federal Programs

The government described different routes from Guidant’s allegedly inflated invoices to federal spending. Some invoices went straight to federal facilities. Others reached Medicare through private hospitals’ reported costs.

Veterans Affairs and Defense Department Purchases

Guidant allegedly submitted replacement-device invoices to Department of Veterans Affairs hospitals and Department of Defense facilities that overstated what those buyers owed. The missing warranty credit or rebate was part of that price. Veterans’ hospitals and military facilities allegedly paid more because a benefit used to sell the devices never reached their invoices. Taxpayers bore that cost.

Private Hospitals and Medicare Cost Reports

For private hospitals, the government’s allegation followed the manufacturer’s invoice into the hospital’s financial reporting. Guidant allegedly overstated replacement-device costs on invoices to those hospitals. The hospitals then overstated the costs on their cost reports, causing Medicare to pay more than it should have.

How Does Reimbursement Work for Medical Devices?

Most implanted devices are included in Medicare’s payment for the hospital procedure or stay. Their cost ordinarily sits inside that payment, even when a device code and charge appear on the claim. A replacement credit can change how much Medicare should pay the hospital.

The Centers for Medicare & Medicaid Services explains the hospital side in its June 2026 cardiac-device credit guidance. Manufacturers may replace cardiac devices without cost or provide a credit, and hospitals must identify and track the affected replacement claims. The guidance describes payment reductions for qualifying free replacements and credits.

For a hospital, receiving the benefit and carrying it through to Medicare billing are separate acts. A replacement device credit not passed from supply chain to billing can leave the purchasing records showing a lower cost while the payment record misses the adjustment. The manufacturer’s failure to furnish a credit was the Guidant allegation. A hospital’s failure to report a credit it received is a separate payment problem.

How Is Medicare Fraud Detected?

For replacement credits, detection can depend on matching hospital and manufacturer records to the payment record. The device’s identity, the benefit due, the credit actually granted and the reported cost may sit in different places.

There is also a weakness in relying on the credit-reporting fields themselves. Under the hospital reporting arrangement, replacement condition codes accompanied a credit already disclosed through value code FD. An omitted credit could leave those fields silent. A person who sees the manufacturer’s credit memo and the hospital’s payment record can recognize a mismatch that is invisible in the credit field alone.

What Kind of Proof Is Needed to Be a Whistleblower?

For a replacement-credit case, useful evidence connects the device and the promised benefit to the credit decision, the invoice and the government payment. Our whistleblower experts examine those connections with you, including what people inside the business knew about a credit that should have been granted or reported.

The manufacturer’s credit decision and the hospital’s billing record tell different parts of the story. A sales representative may know what replacement benefit was promised, while someone in accounts payable sees the credit memo and patient financial services handles the claim. We work with you to connect what those departments knew to what the government paid.

In a credit case, that knowledge is specific: why a replacement qualified, who decided what to credit, or how the hospital’s billing staff learned about it. Those are connections we develop with the person who knows the business. An invoice can show the price without explaining why the company withheld a credit. The person who handled the replacement may know that part of the story.

How Much Does a Medicare Fraud Whistleblower Case Pay?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

In the Guidant resolution, the Justice Department said the whistleblower would receive payments totaling more than $2.3 million from the settlement amount.

St. Jude and the Same Missing Benefit

St. Jude Medical agreed to a $3.65 million settlement announced on May 31, 2012, over allegations that it withheld warranty credits when billing Veterans Affairs and the Defense Department for replacement pacemakers and defibrillators. Whistleblowers brought that case too.

The St. Jude settlement was smaller than Guidant’s, but the alleged practice was the same: federal buyers paid more for replacement devices because the manufacturer withheld a warranty benefit. For someone inside cardiac-device purchasing, the practical question runs through both cases: did the replacement price reflect the credit the buyer was entitled to receive?

You Know Where the Credit Went

If you saw a promised replacement credit disappear from an invoice or fail to reach hospital billing, speak to one of our whistleblower experts about the credit that went missing. We connect your knowledge of the device and the credit decision to the federal payment and bring in medical device fraud whistleblower lawyers who understand hospital reimbursement. We stay beside you throughout the process to build your strongest medical device whistleblower case.